London, UK, 16 July 2013: BTG plc (LSE: BTG), the specialist healthcare company, today announces its interim management statement for the period from 1 April 2013 to 15 July 2013.

Boston Scientific today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used ...

BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology ...

BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company ...

Contacts Nordion Inc. INVESTORS: Ana Raman, (613) 595-4580 [email protected] or MEDIA: Shelley Maclean, (613) 592-3400 x. 2414 [email protected] ...

BTG plc is a UK pharmaceutical company specializing in antivenoms, oncology drugs and treatments for varicose veins. BTG's snakebite antivenom, Crofab, has been the most significant contributor to ...

LONDON, July 16, 2019 /PRNewswire/ -- BTG International Asia Limited, a subsidiary of BTG plc (LSE: BTG) announced today that it has agreed to invest RMB 76million (approximately USD 11million) in ...

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

Boston Scientific Corporation (NYSE: BSX) Boston Scientific Announces Recommended Offer to Acquire BTG PLC November 20, 2018 7:15 AM ET Executives Susan Lisa - Vice President of Investor Relations ...

IAN HARVEY is the Chief Executive Officer of BTG Plc. He has an MA in Mechanical Sciences from Cambridge University and an MBA from Harvard University. He was with Vickers and then Laporte ...

Banco BTG Pactual SA, Latin America’s largest independent investment bank, agreed to buy HSBC Holdings Plc’s operations in ...

MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc.